Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STATIN-C3: Morning vs Bedtime Statins
NCT06856772Phase 4Not yet recruiting
- Start
- Feb 2025
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in cardiovascular diseases (CVD) and atherosclerosis (2 arms). Primary endpoint: Composite of hospitalization for myocardial infarction, hospitalization for stroke or cardiovascular death at 5 years. Planned start Feb 2025; status: not yet recruiting.
02
Conditions
cardiovascular diseases (CVD)atherosclerosis
Beyond the preview
Go deeper on NCT06856772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06856772.